CannX is introducing free webinar series to keep you informed and connected.

Past webinars:

Webinar: Cannabis: Friend or foe? An evidence-based debate

Date: December 20, 2021 @ 04:00 PM CET / 05:00 PM Israel IST / 10:00 AM EST 

The use of cannabis for treatment of different medical conditions is constantly increasing in many places around the world. While evidence is accumulating to support the integration of cannabis into healthcare, this process is still in its infancy. Moreover, despite the therapeutic potential of cannabis and cannabinoids, this treatment modality remains associated with numerous uncertainties and controversies. At the same time, legalization of cannabis for adult use is enacted in more and more places and considered in other jurisdictions. This trend is associated with even more health-related concerns, both in the individual level and for public health in general.

In this CannX webinar, two distinguished physicians will carry out an evidence-based debate about the pros and cons of medical cannabis. They will engage with the audience to determine together: is cannabis a friend or a foe? The debate will delve into such questions as what limits, if any, should be imposed on THC content? Should edibles be allowed or banned? How should driving under the influence of medical cannabis be regulated?

Dr. Leslie Mendoza Temple is a Clinical Associate Professor for NorthShore University HealthSystem’s Department of Family Medicine and Medical Director of the NorthShore Integrative Medicine Program. She was recently appointed as an endowed Chair of Integrative Medicine by the Owen L. Coon Foundation. She is also a Clinical Associate Professor in Family Medicine at the University of Chicago Pritzker School of Medicine. From 2014-2016, Dr. Temple served as Chair of the Medical Cannabis Advisory Board for the Illinois Department of Public Health.

Dr. Jerrold Leikin is an Adjunct Clinical Professor on the Division of Environmental and Occupational Health Sciences and the Occupational and Environmental Medicine Service of UI Health at the University of Illinois at Chicago and a Professor of Medicine at Rosalind Franklin University of Medicine & Science in North Chicago, Il. Dr. Leikin is Board Certified in Internal Medicine, Emergency Medicine, Medical Toxicology and Addiction Medicine. He has published more than 200 articles in peer-reviewed medical journals. In this debate Dr. Leikin will defend the thesis of “cannabis as a foe”.

Moderator: Yuval Zolotov, Ph.D., Ben Gurion University of the Negev (Israel)

Speakers:

• Leslie Mendoza Temple, MD, ABOIM, Integrative Medicine Program, NorthShore University HealthSystem; Clinical Associate Professor, Family Medicine, University of Chicago Pritzker School of Medicine, USA
• Jerrold Blair Leikin, MD, FACP, FACEP, FACMT, FAACT, FACOEM, FASAM, Adjunct Clinical Professor on the Division of Environmental and Occupational Health Sciences and the Occupational and Environmental Medicine Service of UI Health, University of Illinois, USA

Webinar: Cannabis, Cannabinoids and Cancer Care

Date: June 10, 2021 @ 04:00 PM CEST/05:00 PM Israel IDT / 10:00 AM ET

The prevalence of cannabis use for different aspects of cancer care is constantly increasing. Indeed, cannabis and cannabinoids have been suggested as potential modulators for common and debilitating symptoms which are associated with cancer and anti-cancer treatments, such as pain, loss of appetite, nausea and vomiting. To a certain extent, there is evidence to additionally support the potential of cannabinoids for additional symptoms that impact cancer patients, such as gastrointestinal distress, peripheral neuropathy, as well as depression and anxiety.
Notwithstanding, the body of knowledge is still in its infancy and has several limitations. Furthermore, cancer patients are very heterogenic, thus limiting the possibility to conclusively draw firm conclusions or clinical recommendations. In this CannX webinar, two distinguished oncologists will share their experience of integrating cannabis into cancer care and will present findings from studies that they have recently conducted.
Dr. Marisa Weiss is the founder and chief medical officer of Breastcancer.org, the world’s leading online resource for expert medical and personal information on breast health and breast cancer. In addition to her clinical practice in Pennsylvania (US), she is an author and a sough-after speaker in professional events and in the media. Dr. Weiss will present a study that she led which sheds light on cannabis use among breast cancer patients from the USA.
Prof. Gil Bar Sela is the Director of Oncology & Hematology Division at Emek Medical Canter (Israel). He currently serves as the elected Chairman of the Israeli Association for Clinical Oncology and Radiation Therapy, and also the Chairman of the Clinical Board of Oncology, Ruth and Bruce Rappoprt Faculty of Medicine, Technion Israel Institute of Technology. Prof. Bar-Sela has published extensively in the scientific literature on topics such as palliative care and complementary medicine in oncology. He will present his study on chronic cannabis use during immunotherapy treatments.

Moderator: Dr. Yuval Zolotov, Senior Research Associate, Regional Alcohol and Drug Abuse Research Center, Ben Gurion University of the Negev (Israel)

Speakers:

• Marisa C. Weiss, M.D., Chief Medical Officer and Founder, Breastcancer.org & Breasthealth.org, USA
• Gil Bar-Sela, Prof., Director, Oncology & Hematology Division, Emek Medical Center, Israel

Webinar: National Perspectives on Cannabis Regulations and Research: Part I

Date: March 30, 2021 @ 04:00 PM CEST/05:00 PM Israel IDT

Medical cannabis policies are constantly evolving throughout the globe. Each and every territory has its own unique characteristics as well as a distinct regulatory framework. The non-harmonized regulations have unique implications for scientific and research efforts, as well as for the industry, the global trade, and the conduct of business in general.
As ‘insiders’, local stakeholders hold an exclusive standpoint and insight about the current and prospective developments of medical cannabis within their respective territory. In this CannX webinar, two high-level members of the medical cannabis community will share updated and important information about the development of medical cannabis in their countries: Dr. Marco Ternelli, PhD from Italy and Dr. Paola Cubillos from Colombia.

Moderator: Dr. Yuval Zolotov, Senior Research Associate, Regional Alcohol and Drug Abuse Research Center, Ben Gurion University of the Negev (Israel)

Speakers:

• Paola Cubillos, M.D., N.D., Founder – Pro Cannabis Colombia Association – Procannacol (Colombia)
• Marco Ternelli, PhD., Cannabiscienza, University of Modena and Reggio Emilia (Italy)

Webinar: Real-World Evidence and Medical Cannabis

Date: October 20, 2020 @ 05:00 PM in Jerusalem (GMT+3:00)

The FDA defines Real-World Evidence as the “clinical evidence regarding the usage and potential benefits or risks of a medical product derived from analysis of Real-world data”. Although double-blind randomized trials have been the “holy grail” in clinical studies for decades, Real-World Evidence is increasingly playing an important role in health care decision. This development is partly facilitated by the use of computers, mobile devices and other digital platforms. Given that cannabis is being used by millions of patients worldwide, without being proven as safe and effective by randomized trials, Real-World Evidence is an invaluable tool for advising clinicians and patients alike regarding safe and effective usage of medical cannabis.

In this CannX webinar, two experts of Real-World Evidence on medical cannabis will present substantial data and discuss directions for future developments.

Moderator: Dr. Yuval Zolotov, Senior Research Associate, Regional Alcohol and Drug Abuse Research Center, Ben Gurion University of the Negev (Israel)

Speakers:

• Joshua Aviram Postdoctoral Fellow, Prof. Meiri’s Laboratory of Cancer Biology and Cannabinoid Research, Faculty of Biology, Technion –Institute of Technology (Israel)
• David Berg President & Chief Technical Officer, Strainprint (Canada)

Webinar: Emerging Medical Indications for Cannabinoid-based Therapies

Date: September 17, 2020 @ 05:00 PM in Jerusalem (GMT+3:00)

Cannabinoids have been traditionally used for a limited number of indications, such as multiple sclerosis and chemotherapy-induced nausea. In recent years, however, both scientific evidence and clinical experience are pointing to the potential of cannabis and cannabinoids for treating new medical indications. In this webinar, two clinicians will share their vast experience of using cannabinoids as a promising treatment option.

Moderator: Dr. Yuval Zolotov, Senior Research Associate, Regional Alcohol and Drug Abuse Research Center, Ben Gurion University of the Negev (Israel)

Speakers:

• Vincent Maida, Associate Professor, University of Toronto & Medical Director, Hospice Vaughan (Canada)
• Addie Ron, Medical Director, Nia Medic Healthcare & Research Services (Israel)

Webinar: Medical Cannabis and the Capital Market: Current Trends and Future Perspectives

Date: August 19, 2020 @ 4 PM CET, 10 AM EST

Three international capital experts will discuss the current trends of the medical cannabis marketplace, as well as the challenges associated with fund raising in times of economic recession and limited international trading. They will additionally share insights about future perspectives of this market.

Moderator: Yael Meir, Chief Operations Officer, Cann10 (Israel)

Speakers:

• Ms. Shiry Eden, Founder and CEO @ Nishot (Israel)
• Ms. Meris Kott, CEO @ Redfund Capital Corp (USA/Canada)
• Mr. Ronnie Jaegermann, Venture Partner @ Beyond Ventures (Israel)

Webinar: The Long and Bumpy Road of Turning Cannabis into Medicine

Date: 23 July 2020 @ 4 PM CET

In this webinar of CannX, two distinguished scientists will present innovative concepts and pathways to overcome the challenges associated with turning the cannabis plant into medicine in modern times.

Moderator: Dr. Yuval Zolotov, Senior Research Associate, Regional Alcohol and Drug Abuse Research Center, Ben Gurion University of the Negev (Israel)

Speakers:

• Hinanit Koltai, Institute of Plant Science, ARO, Volcani Center (Israel)
• Fabricio Pamplona, Head of Science – CSO at Proprium Health Technology and Science (Brazil)